About Us

Guidelines Committee Members:

The expert panel that developed the International Guidelines for the Diagnosis and Management of Pyruvate Kinase Deficiency included 29 physicians, geneticists, laboratory specialists, a nurse, a guidelines methodologist, patients with PK deficiency, and caregivers from 10 countries. The website is supported by funding from an unrestricted grant to develop the guidelines and funding from the nonprofits Pyruvate Kinase Deficiency Foundation and Thrive with Pyruvate Deficiency Organization

  • Hanny Al-Samkari, MD Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
  • Nadine Shehata, MD, MSc, Departments of Medicine and Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
  • Kelly Lang-Robertson, MLIS, Centre for Effective Practice, Toronto, Ontario, Canada
  • Paola Bianchi, PhD, Hematology Unit, Pathophysiology of Anemias Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Andreas Glenthøj, MD, Ph, Danish Red Blood Cell Center, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
  • Sujit Sheth, MD, Division of Pediatric Hematology/Oncology, Weill Cornell Medicine, New York, New York, United States
  • Ellis J Neufeld, MD, PhD, Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States
  • David C Rees, MBBS, Department of Paediatric Haematology, King’s College London, King's College Hospital, London, United Kingdom
  • Satheesh Chonat, MD, Pediatric Hematology/Oncology, Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
  • Kevin HM Kuo, MD, Division of Medical Oncology and Hematology, University Health Network, University of Toronto, Ontario, Canada

  • Jennifer A Rothman, MD, Duke University Medical Center, Durham, North Carolina, United States
  • Wilma Barcellini, MD, Hematology Unit, Pathophysiology of Anemias Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Eduard J van Beers, MD, PhD, Benign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
  • Dagmar Pospíšilová, MD, PhD, Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
  • Ami J Shah, MD, Division of Stem Cell Transplantation and Regenerative Medicine, Lucile Packard Children Hospital, Stanford School of Medicine, Palo Alto, California, United States
  • Richard van Wijk, PhD, Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
  • Bertil Glader, MD, PhD, Division of Pediatric Hematology/Oncology, Lucile Packard Children Hospital, Stanford School of Medicine, Palo Alto, California, United States
  • Maria Del Mar Mañú Pereira, PhD, Rare Anaemia Disorders Research Laboratory, Institut de Recerca – Hospital Universitari Vall d’Hebron, Barcelona, Spain
  • Oliver Andres, MD, Centre of Inherited Blood Cell Disorders, University Hospital Würzburg, Würzburg, Germany;
  • Theodosia A Kalfa, MD, PhD, Division of Hematology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States

  • Stefan W Eber, MD, Department of Pediatrics, Practice for Pediatric Hematology and Hemostaseology, University Children's Hospital, Technical University, Munich, Germany
  • Patrick G Gallagher, MD, Department of Pediatrics, Center for Perinatal Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, United States
  • Janet L Kwiatkowski, MD MSCE, Division of Hematology, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Frédéric Galacteros, MD, Unit for Red Cell Genetic Disorders, Henri Mondor Hospital, Créteil, France;
  • Tamara J Schryver, PhD, Thrive with Pyruvate Kinase Deficiency Organization, Bloomington, Minnesota, United States
  • Carl Lander, RN, Thrive with Pyruvate Kinase Deficiency Organization, Bloomington, Minnesota, United States
  • Alejandra Watson, Pyruvate Kinase Deficiency Foundation, Walled Lake, Michigan, United States;
  • Riyad Elbard, Thalassemia International Federation, Nicosia, Cyprus
  • Dore Peereboom, Rare Blood Diseases Foundation, Arnhem, Gelderland, The Netherlands
  • Rachael F Grace, MD, MMsc, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, United States